1. Home/
  2. Compounds/
  3. carboplatin:etoposide (40:17 mol/mol)

carboplatin:etoposide (40:17 mol/mol)


SourcesNames Used
CTRPv2carboplatin:etoposide (40:17 mol/mol)
PharmacoGx carboplatin:etoposide (40:17 mol/mol)

Cell lines tested with carboplatin:etoposide (40:17 mol/mol)

829 cell lines have been tested with this compound, using data from 1 dataset(s).
CAL-62 thyroid CTRPv21
CAL-29 urinary tract CTRPv21
CAL-120 breast CTRPv21
BFTC-909 urinary tract CTRPv21
BFTC-905 urinary tract CTRPv21
253J-BV urinary tract CTRPv21
MKN1 stomach CTRPv21
KPL-1 breast CTRPv21
CAS-1 central nervous system CTRPv21
Download CSV

Tissues tested with carboplatin:etoposide (40:17 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
haematopoietic and lymphoid tissueCTRPv2147
central nervous systemCTRPv246
large intestineCTRPv244
upper aerodigestive tractCTRPv232
Download CSV
Download Data as CSV

Top molecular features associated with response to carboplatin:etoposide (40:17 mol/mol)

Feature TypeStandardized
Nominal ANOVA
mRNA HNRNPA1L2 CTRPv2 AAC 0.32 7e-20
mRNA LMNB1 CTRPv2 AAC 0.28 1e-18
mRNA HNRNPA0 CTRPv2 AAC 0.27 2e-18
mRNA YPEL1 CTRPv2 AAC 0.27 4e-18
mRNA HNRNPDL CTRPv2 AAC 0.28 5e-18
mRNA HNRNPA1 CTRPv2 AAC 0.28 3e-17
mRNA SLFN11 CTRPv2 AAC 0.26 3e-17
mRNA ZNF445 CTRPv2 AAC 0.28 1e-16
mRNA ARHGAP19 CTRPv2 AAC 0.3 3e-16
mRNA CDCA7 CTRPv2 AAC 0.27 3e-16
Download CSV